Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study.
Τίτλος | Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Loi, E. Stochino, Pontis A., Cofelice V., Pirarba S., Fais M. Francesca, Daniilidis A., Melis I., Paoletti A. Maria, & Angioni S. |
Journal | Int J Womens Health |
Volume | 11 |
Pagination | 443-449 |
Date Published | 2019 |
ISSN | 1179-1411 |
Abstract | Purpose: The aim of the present study was to evaluate the effectiveness of the ultramicronized-palmitoylethanolamide (um-PEA) and co-micronised palmitoylethanolamide/polydatin m(PEA/PLD) in the management of chronic pelvic pain related to endometriosis in patients desiring pregnancy. |
DOI | 10.2147/IJWH.S204275 |
Alternate Journal | Int J Womens Health |
PubMed ID | 31496832 |
PubMed Central ID | PMC6697671 |